Form 4: Sangamo Therapeutics SVP Scott Willoughby Reports Tax-Related Share Disposition
SEC Form 4 Filing
Scott Willoughby, SVP, General Counsel & Secretary of Sangamo Therapeutics, reports disposition of shares for tax withholding purposes related to RSU vesting.
Summary
- On January 22, 2025, Scott B. Willoughby, SVP, General Counsel & Secretary of Sangamo Therapeutics, Inc., disposed of 129,549 shares of common stock at a price of $1.15 per share.
- This disposition was solely for mandatory tax withholding purposes related to the vesting of a restricted stock unit (RSU) grant.
- The shares were surrendered to the Issuer, Sangamo Therapeutics, Inc., pursuant to the terms of the company's Amended and Restated 2018 Equity Incentive Plan.
- Following the transaction, Willoughby directly owns 697,651 shares of Sangamo Therapeutics common stock.
- These shares include those resulting from the January 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in one final installment on February 25, 2025 and shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to insider transactions. It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax-related transaction and doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| February 25, 2022 | Date of RSU grant, 3,844 shares subject to the grant will vest in one final installment on February 25, 2025. |
| February 24, 2023 | Date of RSU grant, 20,039 shares subject to the grant will vest in successive equal quarterly installments through February 24, 2026. |
| January 22, 2024 | Date of RSU grant, the remaining 356,250 shares will vest in successive equal quarterly installments through January 22, 2026. |
| January 22, 2025 | Date of transaction: Disposition of 129,549 shares for tax withholding; vesting installment of the January 22, 2024 RSU grant. |
| February 25, 2025 | Final vesting installment of the February 25, 2022 RSU grant (3,844 shares). |
| January 22, 2026 | Final vesting installment of the January 22, 2024 RSU grant. |
| February 24, 2026 | Final vesting installment of the February 24, 2023 RSU grant. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.